Related Experiment Video
Updated: Aug 11, 2026
04:12
Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma
Published on: January 19, 2024
[Lentigo maligna treated with 5% imiquimod cream]
Trinidad Martín1, Antonio Ojeda, Silvestre Martínez
1Servicio de Dermatología, Hospital Civil, Complejo Hospitalario Carlos Haya, Málaga, Spain. Trinim@hotmail.com
Actas Dermo-Sifiliograficas
|February 16, 2006
Summary
Lentigo maligna (LM), a precursor to melanoma, can be effectively treated with topical 5% imiquimod cream. This immunomodulator offers a promising alternative therapeutic response for patients with this skin condition.
Area of Science:
- Dermatology
- Oncology
Background:
- Lentigo maligna (LM) is an early-stage form of lentigo maligna melanoma.
- Untreated LM has a 30-35% risk of progressing to invasive melanoma.
- Standard treatments include surgical excision or Mohs microsurgery.
Observation:
- A case study involving a patient diagnosed with lentigo maligna.
- The patient was treated with topical 5% imiquimod cream.
- The treatment demonstrated a significant positive outcome.
Findings:
- Topical 5% imiquimod cream showed an excellent therapeutic response in the treated patient.
- Imiquimod acts as a topical immunomodulator, stimulating innate and acquired immunity.
- This suggests a potential non-surgical treatment option for lentigo maligna.
Implications:
- Topical imiquimod may offer a viable, less invasive treatment for lentigo maligna.
- Further research into imiquimod's efficacy and safety for LM is warranted.
- This approach could expand treatment options for lentigo maligna melanoma precursors.
Related Concept Videos
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.